North Macedonia vs Trinidad and Tobago: Number of clinical trials
North Macedonia
2 trials
in 2023
Trinidad and Tobago
2 trials
in 2023
North Macedonia rank
108th
Trinidad and Tobago rank
108th
Number of clinical trials over time
- North Macedonia
- Trinidad and Tobago
How they compare
North Macedonia currently reports 2 trials against 2 trials in Trinidad and Tobago, a difference of 0 trials.
The two have swapped places 1 time across 5 shared years of data; in 2010 it was North Macedonia ahead.
North Macedonia ranks 108th and Trinidad and Tobago ranks 108th of 153 countries.
North Macedonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | North Macedonia | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5 trials | 1 trials | 0.5 trials | North Macedonia |
| 2020s | 2.67 trials | 2.67 trials | 0 trials | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, North Macedonia or Trinidad and Tobago?
- North Macedonia, at 2 trials against 2 trials in Trinidad and Tobago as of 2023.
- What is the difference in number of clinical trials between North Macedonia and Trinidad and Tobago?
- 0 trials, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Trinidad and Tobago?
- 5 years are reported by both, from 2010 to 2023.
- How do North Macedonia and Trinidad and Tobago rank globally for number of clinical trials?
- North Macedonia ranks 108th and Trinidad and Tobago ranks 108th of 153 countries.
- Where does this data come from?
- ClinicalTrials.gov (2025) – with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.